retatrutide triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept Retatrutide 10mg — Triple Agonist
Description
Chin J Pathophysiol 2016;32:1312-6
Theres very littleif anytransfer into breast milk for semaglutide injections, which is great news
I received word from him early Monday morning that he was taking semaglutide 0.25mg daily until we talk again Friday to increase his dose
Both are still on the market, but new prescriptions are increasingly going to semaglutide- or tirzepatide-based options because of greater effectiveness on blood sugar and weight
